Istituto Nazionale Tumori Regina Elena
About Istituto Nazionale Tumori Regina Elena
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Istituto Nazionale Tumori Regina Elena
During the past decade, Istituto Nazionale Tumori Regina Elena conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 17 clinical trials were completed, i.e. on
average, 39.5% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 11 clinical trials were completed. i.e. 45.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
2009-03-01
2013-04-09
Completed
861
Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
2008-03-01
2014-12-01
Completed
320
A Safety Study in Patients With Advanced Prostate Cancer Treated With FIRMAGON
2011-01-01
2018-03-27
Completed
1,493
Very Low Tidal Volume vs Conventional Ventilatory Strategy for One-lung Ventilation in Thoracic Anesthesia
2013-09-01
2017-09-01
Completed
984
A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma
2012-09-24
2018-07-13
Completed
498
A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma
2013-01-08
2019-07-21
Completed
495
Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
2013-07-12
2019-06-04
Completed
402
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Istituto Nazionale Tumori Regina Elena" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Janssen Research & Development, LLC" with 9 trials
sponsored, "Celgene" with 4 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 4 trials sponsored and "Incyte Corporation"
with 4 trials sponsored. Other sponsors include 25 different institutions and
companies that sponsored additional 30 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Istituto Nazionale Tumori Regina Elena"
#1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Alleanza Contro il Cancro" with 1 trials as a collaborator, "BAYER S.p.A. - Italia" with 1 trials as a collaborator, "Bocconi University" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were
collaborators in the rest 17 trials.
Clinical Trials Conditions at Istituto Nazionale Tumori Regina Elena
According to Clinical.Site data, the most researched conditions in "Istituto Nazionale Tumori Regina Elena" are
"Carcinoma, Non-Small-Cell Lung" (6 trials), "Melanoma" (6 trials), "Neoplasms" (4 trials), "Breast Cancer" (3 trials) and "Carcinoma, Bronchogenic" (3 trials). Many other conditions were trialed in "Istituto Nazionale Tumori Regina Elena" in a lesser frequency.
Clinical Trials Intervention Types at Istituto Nazionale Tumori Regina Elena
Most popular intervention types in "Istituto Nazionale Tumori Regina Elena" are "Drug" (51 trials), "Biological" (5 trials), "Radiation" (4 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Gemcitabine" (7 trials), "Carboplatin" (6 trials), "Docetaxel" (5 trials), "Placebo" (5 trials) and "Cisplatin" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Istituto Nazionale Tumori Regina Elena
The vast majority of trials in "Istituto Nazionale Tumori Regina Elena" are
54 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Istituto Nazionale Tumori Regina Elena
Currently, there are NaN active trials in "Istituto Nazionale Tumori Regina Elena".
undefined are not yet recruiting,
24 are recruiting,
11 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 19 completed trials in Istituto Nazionale Tumori Regina Elena,
1 suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Istituto Nazionale Tumori Regina Elena, 6 "Phase 1"
clinical trials were conducted, 20 "Phase 2" clinical
trials and 33 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".